Class 1. Pulmonary Hypertension Associated with Congenital Cardiovascular Disease

Long-Term Follow-Up of Pediatric Patients with Severe Postoperative Pulmonary Hypertension After Correction of Congenital Heart Defects

Lars LindbergLund University and Skane University HospitalSweden Pediatric CardiologyPediatr Cardiol 2022; 43: 827-836DOI: 10.1007/s00246-021-02794-9 AbstractThe surgical repair of congenital heart defects in children with preoperative pulmonary hypertension (PH) is to varying degree associated with the occurrence of postoperative PH. The objective of this study was to follow up children with severe postoperative PH (pulmonary arterial/aortic pressure […]

Long-Term Follow-Up of Pediatric Patients with Severe Postoperative Pulmonary Hypertension After Correction of Congenital Heart Defects Read More »

Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension

Samuel J. Gentle, Colm P. Travers, Matthew Clark, Waldemar A. Carlo, Namasivayam AmbalavanamUniversity of Alabama at Birmingham.United States American Journal of Respiratory and Critical Care MedicineAm J Respir Crit Care Med 2022; DOI: 10.1164/rccm.202203-0570OC AbstractBackground: Extremely preterm infants with evolving bronchopulmonary dysplasia (BPD) are at risk for development of BPD-associated pulmonary hypertension (BPD-PH). The presence and duration

Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension Read More »

Transcatheter closure of congenital portosystemic shunts – A multicenter experience

Nageswara Rao Koneti, Shweta Bakhru, Mahimarangaiah Jayranganath, Mahesh Kappanayil, Prashant Bobhate, Lakshmivenkateshiah Srinivas, Snehal Kulkarni, Usha Mandikal Kodandarama Sastry, Raman Krishna KumarRainbow Children’s Heart Institute. Sri Jayadeva Institute of Cardiovascular Sciences and Research. Amrita Institute of Medical Sciences. Kokilaben Ambani Hospital. Jupiter Hospital.India Annals of Pediatric CardiologyAnn Pediatr Cardiol 2022; 15: 114-120DOI: 10.4103/apc.apc_5_22 AbstractBackground: Congenital portosystemic shunts

Transcatheter closure of congenital portosystemic shunts – A multicenter experience Read More »

Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension

Hythem Nawaytou, Nancy K. Hills, Ronald I. ClymanUniversity of California San Francisco.United States Pediatric ResearchPediatr Res 2023; DOI: 10.1038/s41390-023-02522-4 AbstractBackground: The aim of the study was to determine whether prolonged exposure to a moderate/large patent ductus arteriosus left-to-right shunt (PDA) increases the risk of late (beyond 36 weeks) pulmonary hypertension (BPD-PH) and pulmonary vascular disease (BPD-PVD) during

Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension Read More »

Multifactorial pulmonary hypertension in infantile scimitar syndrome

Damien Bonnet, Isabelle Szezepanski, Christophe Delacourt, Sophie Malkezadeh-Milani, Maryline LévyHôpital Necker-Enfants Malades, AP-HP, Université de ParisFrance Archives of Cardiovascular DiseaseArch Cardiovasc Dis 2022; 115: 142-150DOI: 10.1016/j.acvd.2022.01.004 AbstractBackground: Pulmonary hypertension in infantile scimitar syndrome is highly prevalent at diagnosis, and has a multifactorial origin.Aims: To analyse the constellation of anatomical anomalies and initial physiology, and their contribution to

Multifactorial pulmonary hypertension in infantile scimitar syndrome Read More »

Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study

Kelly C. O. Abud, Clarisse M. Machado, Lucy S. Vilas Boas, Nair Y. Maeda, Eloisa S. Carvalho, Maria Francilene S. Souza, Paula V. Gaiolla, Claudia R. P. Castro1 Juliana Pereira, Marlene Rabinovitch, Antonio Augusto LopesUniversity of São Paulo School of Medicine, Pró-Sangue Foundation, Stanford University School of MedicineBrazil and United States European Journal of Medical

Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study Read More »

Randomized, controlled study of inhaled nitric oxide following surgery for congenital heart disease

Ronald W. Day, John A. Hawkins, Edwin C. McGough, Kevin L. Crezee, Garth S. OrsmondUniversity of Utah and Primary Children’s HospitalUnited States Annals of Thoracic SurgeryAnn Thorac Surg 2000; 69: 1907-1913DOI: 10.1016/s0003-4975(00)01312-6 AbstractBackground: Inhaled nitric oxide selectively decreases pulmonary vascular resistance. This study was performed to determine whether inhaled nitric oxide decreases the incidence of pulmonary hypertensive

Randomized, controlled study of inhaled nitric oxide following surgery for congenital heart disease Read More »

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance

Ronald W. DayUniversity of Utah and Primary Children’s HospitalUnited States International Journal of Cardiology Congenital Heart DefectsInt J Cardiol Congenit Heart Dis 2021;doi.org/10.1016/j.ijcchd.2021.100184 AbstractBackground. Based upon expert opinion, guidelines have been proposed for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance. This study reports the accuracy of published guidelines using a dataset

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance Read More »

Scroll to Top